Insider Trading: Allergan Inc (AGN.N)

AGN.N on New York Stock Exchange

127.80USD
15 Apr 2014
Price Change (% chg)

$3.83 (+3.09%)
Prev Close
$123.97
Open
$124.31
Day's High
$127.91
Day's Low
$123.98
Volume
1,227,870
Avg. Vol
605,002
52-wk High
$132.04
52-wk Low
$81.34

Search Stocks
WHITCUP SCOTT M Options Exercised: 0
Trade Date: Thursday, 6 Dec 2012 Price: 91.23
Title: Officer Shares Held: 26,421
Type Traded: Direct Net Change in Shares This Filing: 0

Institutional Holders

% Shares Owned: 89.95%
# of Holders: 916
Total Shares Held: 269,054,562
3 Mo. Net Change: 140,489
# New Positions: 17
# Closed Positions: 7
# Increased Positions: 42
# Reduced Positions: 34
# Net Buyers: 8

Officers & Directors

Name Age Since Current Position

David Pyott

59 2013 Chairman of the Board, Chief Executive Officer, Principal Executive Officer

Douglas Ingram

50 2013 President

Jeffrey Edwards

52 2005 Chief Financial Officer, Principal Financial Officer, Executive Vice President - Finance and Business Development

Scott Whitcup

54 2009 Executive Vice President - Research & Development, Chief Scientific Officer

Arnold Pinkston

54 2011 Executive Vice President, General Counsel, Assistant Secretary

Scott Sherman

47 2010 Executive Vice President - Human Resources

Raymond Diradoorian

55 2006 Executive Vice President - Global Technical Operations

James Barlow

54 2005 Senior Vice President, Corporate Controller, Principal Accounting Officer

Julian Gangolli

55 2011 Corporate Vice President and President, North America

Michael Gallagher

67 2013 Lead Independent Director

Henri Termeer

2014 Director

Deborah Dunsire

51 2006 Independent Director

Trevor Jones

70 2004 Independent Director

Louis Lavigne

65 2005 Independent Director

Peter McDonnell

54 2013 Independent Director

Timothy Proctor

63 2013 Independent Director

Russell Ray

65 2003 Independent Director

Jim Hindman

IR Contact Officer
Search Stocks